CNBX Pharmaceuticals Inc. (CNBX) Comparison with companies in other sectors?

CNBX Pharmaceuticals Inc. has a share price of 92.51M. You can analyze CNBX Pharmaceuticals Inc. (CNBX) competitors across different market sectors through stock heatmaps.

What are CNBX's NET and operating margins?

CNBX Pharmaceuticals Inc. (CNBX) operating margin is around -17.44, and net profit margin is approximately -16.81 as of the latest reports.

In what way does CNBX's earnings per share (EPS) trend reflect its financial momentum?

CNBX Pharmaceuticals Inc. (CNBX) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for CNBX Pharmaceuticals Inc. is -0.04, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for CNBX Pharmaceuticals Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for CNBX Pharmaceuticals Inc. like P/E which is -0.05, P/B which is -0.01, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

CNBX Pharmaceuticals Inc.

CNBX•PNK

Healthcare

Biotechnology

$0.00

$-0.00(-20.00%)

CNBX Pharmaceuticals Inc. (CNBX) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.01

P/E Ratio

-0.04

ROE

0.12%

Net Margin

-16.81%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$37.01K

Shares OutstandingTotal number of shares issued

$92.51M

Book Value/ShareNet worth per share

$-0.08

Revenue/ShareAnnual revenue per share

$0.001

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

-1681.02%

Operating MarginOperating income as percentage of revenue

-1743.83%

ROEReturn on shareholders' equity

11.79%

ROAReturn on total assets

-583.02%

ROCEReturn on capital employed

11.92%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.00

Cash/ShareCash and equivalents per share

$0.001

FCF YieldFree cash flow as percentage of market cap

-374.99%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for CNBXFinancial Ratios Analysis details for CNBX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CNBXSector Benchmarking details for CNBX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for CNBX Pharmaceuticals Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of CNBX Pharmaceuticals Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account CNBX Pharmaceuticals Inc.'s unique business strengths and challenges.

Key Financial Metrics for CNBX Pharmaceuticals Inc.

For CNBX Pharmaceuticals Inc., essential financial indicators include EPS -0.01, PE -0.04, and ROE 0.12. These key ratios reveal insights into CNBX Pharmaceuticals Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare CNBX Pharmaceuticals Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of CNBX Pharmaceuticals Inc.

Metrics like Net Margin -1681.02% and ROA -583.02% shed light on how well CNBX Pharmaceuticals Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether CNBX Pharmaceuticals Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of CNBX Pharmaceuticals Inc.

Using ratios such as P/B Ratio -0.01 and PEG Ratio -0.00, investors can assess whether CNBX Pharmaceuticals Inc. is appropriately valued based on its financials and growth potential. These figures, combined with CNBX Pharmaceuticals Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for CNBX Pharmaceuticals Inc.

Financial health indicators, such as Debt/Equity Ratio -0.54 and Cash Flow $-0.00, provide a snapshot of CNBX Pharmaceuticals Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like CNBX Pharmaceuticals Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for CNBX Pharmaceuticals Inc.

Investing in CNBX Pharmaceuticals Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at CNBX Pharmaceuticals Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;